During the past decade, The First affiliated Hospital of Guangdong Pharmaceutical University conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First affiliated Hospital of Guangdong Pharmaceutical University" #1 sponsor was "Sun Yat-sen University" with 5 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 3 trials sponsored, "Akeso" with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "First Affiliated Hospital, Sun Yat-Sen University" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First affiliated Hospital of Guangdong Pharmaceutical University" #1 collaborator was "Anhui Provincial Hospital" with 2 trials as a collaborator, "Anqing Municipal Hospital" with 2 trials as a collaborator, "First Affiliated Hospital of Wannan Medical College" with 2 trials as a collaborator, "Guangdong Provincial Hospital of Traditional Chinese Medicine" with 2 trials as a collaborator and "Lishui hospital of Zhejiang University" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "The First affiliated Hospital of Guangdong Pharmaceutical University" are "Cervical Cancer" (2 trials), "Gastric Cancer" (2 trials), "Acute Coronary Syndrome" (1 trials), "Adjuvant Chemotherapy" (1 trials) and "Advanced Non-squamous Cell Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "The First affiliated Hospital of Guangdong Pharmaceutical University" in a lesser frequency.

Most popular intervention types in "The First affiliated Hospital of Guangdong Pharmaceutical University" are "Drug" (15 trials), "Other" (3 trials), "Radiation" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (2 trials), "Placebo" (2 trials), "Acarbose" (1 trials), "Anlotinib hydrochloride capsule" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "The First affiliated Hospital of Guangdong Pharmaceutical University" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "The First affiliated Hospital of Guangdong Pharmaceutical University". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The First affiliated Hospital of Guangdong Pharmaceutical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The First affiliated Hospital of Guangdong Pharmaceutical University, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".